Intravenous thrombolysis before endovascular therapy for large vessel strokes can lead to significantly higher hospital costs without improving outcomes

BACKGROUND: Limited efficacy of IV recombinant tissue plasminogen activator (rt-PA) for large vessel occlusions (LVO) raises doubts about its utility prior to endovascular therapy. PURPOSE: To compare outcomes and hospital costs for anterior circulation LVOs (middle cerebral artery, internal carotid...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neurointerv Surg
Egile Nagusiak: Rai, Ansaar T, Boo, SoHyun, Buseman, Chelsea, Adcock, Amelia K, Tarabishy, Abdul R, Miller, Maurice M, Roberts, Thomas D, Domico, Jennifer R, Carpenter, Jeffrey S
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2018
Gaiak:
Ischemic Stroke
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5749313/
https://ncbi.nlm.nih.gov/pubmed/28062805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/neurintsurg-2016-012830
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak